Studies blood sugar control across the menstrual cycle in women with type 1 diabetes
Observes how an automatic insulin system adapts across the menstrual cycle in women with diabetes.
Plain-language title generated from the registry record
Registry title: Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1).
Key facts
- Where
- Madrid, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Source: NCT06338072, who can take part
Where in Spain
- Lía Nattero-ChávezMadrid, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Trial code
- NCT06338072
- Record updated
- 7 August 2025
- Original description
The aim of this observational study is to assess the effectiveness of automatic insulin infusion in responding to changes in insulin sensitivity throughout various phases of the menstrual cycle in a cohort of reproductive-aged women with type 1 diabetes, using an advanced closed-loop system. By gaining insights into both the limitations and effectiveness of this adaptation, we aim to inform the enhancement of control algorithms and learning strategies within closed-loop systems. This research is especially vital for addressing the distinct challenges that women commonly encounter in maintaining glycemic control.Read full original descriptionShow less
Impact of the Menstrual Cycle on the Control of Type 1 Diabetes in Reproductive Aged Women Using an Advanced Closed Loop System.
The aim of this observational study is to assess the effectiveness of automatic insulin infusion in responding to changes in insulin sensitivity throughout various phases of the menstrual cycle in a cohort of reproductive-aged women with type 1 diabetes, using an advanced closed-loop system. By gaining insights into both the limitations and effectiveness of this adaptation, we aim to inform the enhancement of control algorithms and learning strategies within closed-loop systems. This research is especially vital for addressing the distinct challenges that women commonly encounter in maintaining glycemic control.
Inclusion: Diagnostic criteria for DM1 according to ADA; Women and men treated with the Medtronic© MinimedTM 780G advanced closed loop system; Women presenting spontaneous regular menstrual cycles with a duration of 24 to 35 days, during the last year; Men under 50 years old; Acceptance of participation in the study and signing of the informed consent.
Exclusion: Institutionalization, serious or terminal illness or renal replacement therapy; Gestation; Use of hormonal contraceptives (including intrauterine devices); Refusal to participate in the study or to sign the informed consent.